"Anti-Bacterial Agents" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Substances that inhibit the growth or reproduction of BACTERIA.
| Descriptor ID |
D000900
|
| MeSH Number(s) |
D27.505.954.122.085
|
| Concept/Terms |
Anti-Bacterial Agents- Anti-Bacterial Agents
- Agents, Anti-Bacterial
- Anti Bacterial Agents
- Antibacterial Agents
- Agents, Antibacterial
- Anti-Bacterial Compounds
- Anti Bacterial Compounds
- Compounds, Anti-Bacterial
Anti-Mycobacterial Agents- Anti-Mycobacterial Agents
- Agents, Anti-Mycobacterial
- Anti Mycobacterial Agents
- Antimycobacterial Agents
- Agents, Antimycobacterial
|
Below are MeSH descriptors whose meaning is more general than "Anti-Bacterial Agents".
Below are MeSH descriptors whose meaning is more specific than "Anti-Bacterial Agents".
This graph shows the total number of publications written about "Anti-Bacterial Agents" by people in this website by year, and whether "Anti-Bacterial Agents" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 13 | 8 | 21 |
| 1997 | 16 | 6 | 22 |
| 1998 | 7 | 11 | 18 |
| 1999 | 9 | 8 | 17 |
| 2000 | 15 | 9 | 24 |
| 2001 | 11 | 10 | 21 |
| 2002 | 19 | 10 | 29 |
| 2003 | 19 | 13 | 32 |
| 2004 | 10 | 11 | 21 |
| 2005 | 18 | 14 | 32 |
| 2006 | 30 | 15 | 45 |
| 2007 | 19 | 23 | 42 |
| 2008 | 26 | 18 | 44 |
| 2009 | 30 | 24 | 54 |
| 2010 | 38 | 23 | 61 |
| 2011 | 40 | 18 | 58 |
| 2012 | 34 | 22 | 56 |
| 2013 | 38 | 30 | 68 |
| 2014 | 44 | 21 | 65 |
| 2015 | 41 | 32 | 73 |
| 2016 | 43 | 26 | 69 |
| 2017 | 61 | 33 | 94 |
| 2018 | 50 | 52 | 102 |
| 2019 | 52 | 48 | 100 |
| 2020 | 42 | 62 | 104 |
| 2021 | 36 | 66 | 102 |
| 2022 | 17 | 69 | 86 |
| 2023 | 11 | 79 | 90 |
| 2024 | 53 | 33 | 86 |
| 2025 | 54 | 30 | 84 |
| 2026 | 14 | 9 | 23 |
To return to the timeline,
click here.
Below are the most recent publications written about "Anti-Bacterial Agents" by people in Profiles.
-
Pneumococcal Pneumonia in Hospitalized Children: 2017-2023. Pediatrics. 2026 May 01; 157(5).
-
Infectious Diseases Society of America (IDSA) Position Statement: Why IDSA Did Not Endorse the Community-Acquired Pneumonia Guidelines 2025 Update. Clin Infect Dis. 2026 Apr 30; 82(4):622-624.
-
Using the Comparing Oral versus Parenteral Antimicrobial Therapy (COPAT) Clinical Trial to Influence Institutional Practice Transformation Towards Earlier Transition to Oral Antibiotics. Clin Infect Dis. 2026 Apr 30; 82(4):e674-e681.
-
Antimicrobial Use in Acute Myocardial Infarction-Related Cardiogenic Shock. J Am Heart Assoc. 2026 Apr 07; 15(7):e047751.
-
Implementation of Diagnostic Stewardship to Improve Urinary Tract Infection Antibiotic Use Across 3 Medical Centers. Clin Infect Dis. 2026 Mar 17; 82(3):494-500.
-
Empiric azithromycin alters the upper respiratory microbiome and resistome without anti-inflammatory benefit in COVID-19. Nat Microbiol. 2026 Apr; 11(4):1100-1112.
-
Candesartan cilexetil disrupts methicillin-resistant Staphylococcus aureus membrane and potentiates gentamicin and polymyxin B activity. Nat Commun. 2026 Mar 15; 17(1).
-
Oral vancomycin for primary sclerosing cholangitis and associated inflammatory bowel disease - paving a path forward. Expert Rev Gastroenterol Hepatol. 2026 Mar; 20(3):233-246.
-
Oral ?-Lactams for Complicated Urinary Tract Infections: A Systematic Review and Point-Counterpoint Comparison With Trimethoprim/Sulfamethoxazole and Fluoroquinolones. Pharmacotherapy. 2026 Mar; 46(3):e70118.
-
Aminoglycosides enhance meropenem/vaborbactam activity against KPC-producing Klebsiella pneumoniae in the hollow fiber infection model. Antimicrob Agents Chemother. 2026 Apr; 70(4):e0136525.